The Role of Emergency Professionals, Nurses and Public Health Professionals in Managing Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory disorder characterized by persistent airflow limitation, chronic inflammation, and progressive respiratory impairment. Its clinical presentation and progression vary considerably among patients, creating challenges for diagnosis, treatment selection, and long-term disease control. Emerging evidence supports personalized approaches that address pulmonary and extrapulmonary disease characteristics. Aim: This review examines recent developments in COPD assessment and management, with particular emphasis on treatable traits, biological therapies, smoking cessation, pulmonary rehabilitation, oxygen therapy, and associated comorbidities. Methods: A narrative review approach was used to discuss evidence concerning COPD pathophysiology, diagnostic investigations, emerging therapeutic strategies, and multidisciplinary management. Particular attention was given to clinical trials investigating targeted biological agents and interventions addressing modifiable disease characteristics. Results: COPD assessment increasingly incorporates spirometry, imaging, inflammatory biomarkers, and functional investigations to identify disease phenotypes and support earlier diagnosis. The treatable traits approach provides a personalized framework for managing pulmonary, extrapulmonary, and behavioral factors, including its potential application in pre-COPD. Among biological therapies, dupilumab has demonstrated reductions in moderate or severe exacerbations and improvements in lung function among patients with elevated blood eosinophils. Evidence supporting IL-5 and TSLP pathway inhibitors remains inconsistent, while IL-33-targeted therapies require further investigation. Smoking cessation, pulmonary rehabilitation, and appropriate oxygen therapy remain essential management strategies. Cardiovascular disease, sleep-disordered breathing, obesity, and dysfunctional breathing also require systematic assessment because they influence clinical outcomes and disease burden. Conclusion: COPD management is evolving toward personalized, multidimensional care. Integrating early diagnosis, treatable traits, targeted therapies, lifestyle interventions, and comorbidity management may improve treatment selection and patient outcomes.

Authors

Institutions

Publication Details

Journal
Saudi Journal of Medicine and Public Health
Published
2026-11-18
DOI
https://doi.org/10.64483/202631878
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Role of Emergency Professionals, Nurses and Public Health Professionals in Managing Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Talal Ali Alsharari, Atallah Zafran Altarfawi, Ahlam Mohammed Jaradi Tayran, Mansour Ibrahim Ahmed Otudi et al.
Saudi Journal of Medicine and Public Health
Chronic Obstructive Pulmonary Disease (COPD) Research
article

The Role of Emergency Professionals, Nurses and Public Health Professionals in Managing Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Talal Ali Alsharari, Atallah Zafran Altarfawi, Ahlam Mohammed Jaradi Tayran, Mansour Ibrahim Ahmed Otudi, Hamzah Shuwaier Ali Salwa, Hassan Jaber Hassan Ammash, Mohammed Muthker M Almutairi, Hussain Hassan H Abushaqarah, Abdullah Msfer Saad Alosaimi, Abdulrahman Abdulaziz Awad Al-Otaibi, Khaled Jumaan Khaled Alghamdi, Hani Muqaybil Alruwaili
article en

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous respiratory disorder characterized by persistent airflow limitation, chronic inflammation, and progressive respiratory impairment. Its clinical presentation and progression vary considerably among patients, creating challenges for diagnosis, treatment selection, and long-term disease control. Emerging evidence supports personalized approaches that address pulmonary and extrapulmonary disease characteristics. Aim: This review examines recent developments in COPD assessment and management, with particular emphasis on treatable traits, biological therapies, smoking cessation, pulmonary rehabilitation, oxygen therapy, and associated comorbidities. Methods: A narrative review approach was used to discuss evidence concerning COPD pathophysiology, diagnostic investigations, emerging therapeutic strategies, and multidisciplinary management. Particular attention was given to clinical trials investigating targeted biological agents and interventions addressing modifiable disease characteristics. Results: COPD assessment increasingly incorporates spirometry, imaging, inflammatory biomarkers, and functional investigations to identify disease phenotypes and support earlier diagnosis. The treatable traits approach provides a personalized framework for managing pulmonary, extrapulmonary, and behavioral factors, including its potential application in pre-COPD. Among biological therapies, dupilumab has demonstrated reductions in moderate or severe exacerbations and improvements in lung function among patients with elevated blood eosinophils. Evidence supporting IL-5 and TSLP pathway inhibitors remains inconsistent, while IL-33-targeted therapies require further investigation. Smoking cessation, pulmonary rehabilitation, and appropriate oxygen therapy remain essential management strategies. Cardiovascular disease, sleep-disordered breathing, obesity, and dysfunctional breathing also require systematic assessment because they influence clinical outcomes and disease burden. Conclusion: COPD management is evolving toward personalized, multidimensional care. Integrating early diagnosis, treatable traits, targeted therapies, lifestyle interventions, and comorbidity management may improve treatment selection and patient outcomes.

Saudi Journal of Medicine and Public HealthVol. 3(1)
King Abdulaziz University (SA), Ministry of Education (SA), Ministry of Health (SA), Saudi Food and Drug Authority (SA)
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon